EirGenix Inc. (TPE:6589)
Taiwan · Delayed Price · Currency is TWD 46.25
-1.05 (-2.22%)
At close: Jul 16, 2026
EirGenix Market Cap
EirGenix has a market cap or net worth of 14.33 billion as of July 16, 2026. Its market cap has decreased by -21.81% in one year.
Market Cap
14.33B
Enterprise Value
12.59B
Revenue
1.13B
Ranking
n/a
PE Ratio
n/a
Stock Price
46.25
Market Cap Chart
Since November 23, 2016, EirGenix's market cap has increased from 4.56B to 14.33B, an increase of 214.34%. That is a compound annual growth rate of 12.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 14.33B | -23.27% |
| Dec 31, 2025 | 18.67B | -15.33% |
| Dec 31, 2024 | 22.05B | -28.29% |
| Dec 29, 2023 | 30.75B | -17.85% |
| Dec 30, 2022 | 37.43B | 11.81% |
| Dec 30, 2021 | 33.48B | 245.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunmax Biotechnology | 20.75B |
| TaiMed Biologics | 17.57B |
| Ever Supreme Bio Technology | 17.10B |
| Lumosa Therapeutics | 16.46B |
| ACRO Biomedical | 16.10B |
| Medigen Vaccine Biologics | 15.07B |
| TCM Biotech International | 14.35B |
| Gongwin Biopharm Holdings | 12.73B |